Skip to Main Content

Paper Details

Oncogenic Genomic Alterations, Clinical Phenotypes, and Outcomes in Metastatic Castration-Sensitive Prostate Cancer.
Clin Cancer Res
94
2020
AR, CDK12, MYC, Metastatic Castration-Sensitive Prostate Cancer, NOTCH, Oncogenic Genomic Alterations, PI3K, SPOP, TP53, WNT, bone metastases, metastatic castration-sensitive disease, metastatic castration-sensitive prostate cancer, patients, tumor, tumor DNA
Author NameAffiliation
Melanie HullingsMemorial Sloan Kettering Cancer Center
Howard I ScherMemorial Sloan Kettering Cancer Center
Howard I ScherWeill Cornell Medical College
Michael J MorrisMemorial Sloan Kettering Cancer Center
Michael J MorrisWeill Cornell Medical College
Nikolaus SchultzMemorial Sloan Kettering Cancer Center
Nikolaus SchultzMemorial Sloan Kettering Cancer Center
Nikolaus SchultzMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Nikolaus SchultzMemorial Sloan Kettering Cancer Center
Nikolaus SchultzMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Nikolaus SchultzMemorial Sloan Kettering Cancer Center
Philip W KantoffMemorial Sloan Kettering Cancer Center
Philip W KantoffWeill Cornell Medical College
Philip W KantoffMemorial Sloan Kettering Cancer Center
Philip W KantoffWeill Cornell Medical College
Wassim AbidaMemorial Sloan Kettering Cancer Center
Wassim AbidaWeill Cornell Medical College
  • 1 - 17

Datasets

Release 1.2